Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
271.00    1.00 (0.37%)
Bid:
267.00
Ask:
275.00
Spread: 8.00 (2.996%)
Market Cap: £359.95m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Commencement of £20m Share Buyback Programme

16 Mar 2026 07:00

RNS Number : 6658W
Restore PLC
16 March 2026
 

16 March 2026

Restore plc ("Restore" or the "Group" or the "Company")

Commencement of £20m Share Buyback Programme

Restore plc (AIM:RST), the UK's leading provider of secure and sustainable business services for data, information, communications and assets, today announces the commencement of a share buyback programme to purchase ordinary shares of 5 pence each in the Company ("Ordinary Shares") for up to £20 million (the "Buyback"), as announced in its full year results published on 12 March 2026.

 

Any ordinary shares purchased by the Company will be cancelled and, accordingly, the Buyback will reduce the Company's share capital.

 

Restore has instructed Investec Bank plc ("Investec") and Canaccord Genuity Limited ("Canaccord") to execute the Buyback. Restore has entered into a non-discretionary and irrevocable instruction with Investec and Canaccord, pursuant to which Investec will execute the first £10m of the Buyback (the "First Tranche") and Canaccord will execute the second £10m of the Buyback (the "Second Tranche"), each acting severally as riskless principal. The First Tranche will commence immediately. The Second Tranche will commence following completion of the First Tranche, and it is anticipated it will end no later than 31 March 2027, subject to market conditions.

 

The maximum number of Ordinary Shares that can be purchased in aggregate under the First Tranche and Second Tranche is 13,692,406, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2025 annual general meeting (the "2025 AGM") and any subsequent authority.

 

Investec and Canaccord will make their trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company, within the terms and pre-set parameters of the Buyback.

 

Any purchase of Ordinary Shares under the Buyback will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The Buyback will be effected under the general authority to repurchase Ordinary Shares granted by the Company's shareholders at the 2025 AGM (and subject to renewed authority at the Company's 12 May 2026 annual general meeting) and in accordance with Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse Regulation.

 

For further information please contact:

 

 

 

Restore plc

www.restoreplc.com

Charles Skinner, CEO

+44 (0) 207 409 2420

Dan Baker, CFO

Chris Fussell, Company Secretary

Investec (Nominated Adviser and Joint Broker)

http://www.investec.com/

Carlton Nelson

+44 (0) 207 597 5970

James Rudd

Thomas Brookhouse

 

 

Canaccord Genuity (Joint Broker)

www.canaccordgenuity.com

Max Hartley

+44 (0) 207 523 8000

Alex Aylen

FTI Consulting (PR Enquiries)

www.fticonsulting.com/uk

Nick Hasell

+44 (0) 203 727 1340

Alex Le May

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDXLFFQXLEBBK
Date   Source Headline
6th Jul 20269:29 amRNSTransaction in Own Shares
29th Jun 202610:36 amRNSTransaction in Own Shares
22nd Jun 202611:34 amRNSTransaction in Own Shares
15th Jun 20269:28 amRNSTransaction in Own Shares
8th Jun 202610:47 amRNSTransaction in Own Shares
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.